BIOMONITOR IV

Intelligence. Confidence. Clarity.

A real challenge exists in the clinical world today with the volume of data generated as more patients benefit from the proven value of long-term cardiac monitoring. Valuable time and resources are spent analyzing false positive arrhythmias, leaving patients waiting for accurate answers. The intelligent technology in BIOTRONIK’s BIOMONITOR IV can help.

BIOTRONIK’s BIOMONITOR IV with SmartECG leverages artificial intelligence (AI) and advanced detection algorithms to reduce 86% of false positives across all major arrhythmias, alleviating the review burden and helping clinicians achieve timely and accurate diagnosis to focus on what’s most important – the patient.

BIOTRONIK’s BIOMONITOR IV is the industry’s first to discriminate between premature ventricular and atrial contractions (PVCs and PACs) and clearly report burden over time.

When it comes to system set-up, BIOMONITOR IV offers indication-specific templates, enhanced automaticity and intuitive reports for efficient access to optimized clinical data and insights. BIOTRONIK Home Monitoring® delivers on the promise of improving patient outcomes and driving operational efficiency.